Key terms
About GALT
Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest GALT news
Apr 09
12:10pm ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Inogen (INGN) and Galectin Therapeutics (GALT)
Apr 05
10:40am ET
Biotech Alert: Searches spiking for these stocks today
Apr 01
12:25pm ET
Buy Rating Affirmed for Galectin Therapeutics Amidst Positive Clinical Trial Progress and Enhanced Financial Stability
Mar 12
8:10am ET
Galectin Therapeutics appoints Khurram Jamil as VP, clinical development
No recent press releases are available for GALT
GALT Financials
Key terms
Ad Feedback
GALT Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
GALT Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
